Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
2.190
-0.050 (-2.23%)
At close: Apr 28, 2026, 4:00 PM EDT
2.174
-0.016 (-0.75%)
After-hours: Apr 28, 2026, 7:44 PM EDT
Daré Bioscience Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Daré Bioscience stock have an average target of 10, with a low estimate of 8.00 and a high estimate of 12. The average target predicts an increase of 356.62% from the current stock price of 2.19.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 2, 2025.
Analyst Ratings
The average analyst rating for Daré Bioscience stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +447.95% | Dec 2, 2025 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $8 | Hold → Strong Buy | Upgrades | $8 | +265.30% | Sep 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +447.95% | Apr 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +447.95% | Dec 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $12 | Strong Buy | Reiterates | $12 | +447.95% | Nov 15, 2024 |
Financial Forecast
Revenue This Year
22.82M
from 1.03M
Increased by 2,115.12%
Revenue Next Year
50.80M
from 22.82M
Increased by 122.62%
EPS This Year
-0.65
from -1.20
EPS Next Year
0.93
from -0.65
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 59.4M | 99.0M | ||||||
| Avg | 22.8M | 50.8M | ||||||
| Low | 532,140 | 5.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 5,666.3% | 333.7% | ||||||
| Avg | 2,115.1% | 122.6% | ||||||
| Low | -48.3% | -77.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 1.29 | 1.85 | ||||||
| Avg | -0.65 | 0.93 | ||||||
| Low | -1.66 | 0.06 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.